Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach? - ScienceDirect
Evaluation of Recently Discontinued Drugs to Identify Factors Contributing to their Failure and to Improve the Efficiency of Pharmaceutical Drug Development | Insight Medical Publishing
The Biopharmaceutical Pipeline:
JOItmC | Free Full-Text | Developing an Improved Risk-Adjusted Net Present Value Technology Valuation Model for the Biopharmaceutical Industry | HTML
Utilizing selection biomarkers in clinical trials: is this the future of drug development? | Biomarkers in Medicine
Clinical development success rates for investigational drugs - Document - Gale OneFile: Health and Medicine
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs - DiMasi - 2010 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Clinical Development Success Rates and Contributing Factors 2011–2020
Box 2 Metrics of success : ' Phase Success ' and ' Likelihood of Approval ' | Semantic Scholar
Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases - DiMasi - 2020 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text
Drug development - Wikipedia
Clinical development success rates for investigational drugs | Nature Biotechnology
Examination of Clinical Trial Costs and Barriers for Drug Development | ASPE
Box 2 Metrics of success : ' Phase Success ' and ' Likelihood of Approval ' | Semantic Scholar
Innovative Trial Designs in GI Drug Development: Why Trials Succeed and Fail—A Brief Report From 2018 Digestive Disease Week - Gastroenterology
PDF) The Success Rate of New Drug Development in Clinical Trials: Crohn's Disease
Clinical development success rates and social value of pediatric Phase 1 trials in oncology | PLOS ONE
Clinical Development of Gene Therapies: The First Three Decades and Counting: Molecular Therapy - Methods & Clinical Development
Examination of Clinical Trial Costs and Barriers for Drug Development | ASPE
Clinical development success rates for investigational drugs - Document - Gale OneFile: Health and Medicine
Drug development - Wikipedia
Artificial Intelligence for Clinical Trial Design - ScienceDirect
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text
